Sunday, May 29, 2016

‘Pathway preferential’ estrogens target the good and avoid the bad

New analogs selectively act on a beneficial biochemical pathway, providing a safer option for estrogen replacement therapy

via Chemical & Engineering News: Biological SCENE http://ift.tt/1TQgSVA
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)